compound tirzepatide weight loss | GLP1 | Medical Compounded Tirzepatide | KEWW Primary

Discovery analysis: what did the study find

Personalization matters here: the Precision Peptide Genetic Test ($99 add-on after your first month) maps your GLP-1 receptor variants to help predict whether you'll respond optimally to standard dosing or may need different timing strategies

"These are all open questions." CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER Akshaya Bhagavathula, Ph.D., an associate professor of epidemiology at North Dakota State University and a fellow of the American College of Epidemiology, said the study is too small to prove causation, and offers an "interesting signal, not a conclusion." Bhagavathula, who was not involved in the study, cautioned that a weaker early buzz could actually lead some people to drink more

Dr Steward said the rise in off-label prescribing is concerning but the results here should still be enough to ring alarm bells

Both products will be available to employers in January 2025.

Competitor data indicates that patients typically lose 5% of their initial body weight on average, and this can increase to over 10% within three months of use